Skip to content
Riskpilot
← Back to search
EN
|
DA
Sign in
Get full access
MedMark AB
AB
Active
Org 5591869440
Ulls Väg 28, 756 51
Uppsala
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2018
0 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
MedMark AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−2
−2
−3
−4
−3
Depreciation & amort.
−0
—
—
—
—
EBIT
−2
−2
−3
−4
−3
Net financials
—
—
−0
—
—
Profit before tax
12
−2
−3
−4
−3
Tax
−1
—
—
—
—
Net profit
11
−2
−3
−4
−3
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
54
52
48
44
41
Equity
53
51
48
44
41
Long-term debt
0
—
—
—
—
Short-term debt
1
1
0
—
—
Total debt
1
1
—
—
—
Financial ratios
5-year trend
EBITDA margin
-291000.0%
This company
15.8%
Market median
-1841872% vs market
2021
2025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2021
2025
Return on equity
-7.1%
This company
18.4%
Market median
-139% vs market
2021
2025
Net profit margin
-291000.0%
This company
8.1%
Market median
-3592693% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on MedMark AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network